NEW YORK - Chinese vitamin C manufacturers on April 11 moved to reduce by $22.5 million a $253.3 million damages award in favor of a direct purchaser class on its allegations that Chinese corporations participated in an illegal cartel to fix prices and limit supply for exports of vitamin C to the United States (In re Vitamin C Antitrust Litigation $(Animal Science Products, Inc., et al. v. Hebei Welcome Pharmaceutical Co. Ltd., et al.$), No. 06-md-1738, No. 05-cv-0453, E.D. N.Y.; See March 2013)...(read more)![]()
↧